查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1905024

全球生技設備市場（按產品、最終用途和地區劃分）—市場規模、產業趨勢、機會分析和預測（2026-2035 年）

Global Biotechnology Instruments Market: By Product, By End-use, Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026-2035
出版日期: | 出版商: Astute Analytica | 英文 240 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

生技設備市場目前正經歷強勁成長，反映出生物技術在醫療、研究和工業應用中日益重要的角色。 2025 年，該市場規模為 921.2 億美元，預計到 2035 年將達到 1,417 億美元。這一預測成長意味著 2026 年至 2035 年預測期內的複合年增長率 (CAGR) 為 4.4%，表明未來十年將保持穩定持續成長。對先進生物技術設備的需求不斷增長是推動市場成長的關鍵因素；這些設備對於在多個領域進行尖端研發至關重要。

推動市場成長的關鍵因素很多。其中一個主要驅動因素是專注於個人化醫療的研發活動激增，個人化醫療根據個人的基因譜量身訂做治療方案。基因組學及相關技術的日益普及需要能夠進行高通量和精確分析的先進儀器，從而推動了整個生物技術設備產業的需求。此外，全球慢性病盛行率的上升也促使人們需要改善診斷和治療方案，進而刺激了對生物技術研究的投入。

市場趨勢

生技設備市場正經歷顯著的整合，賽默飛世爾科技（Thermo Fisher Scientific）和丹納赫公司（Danaher Corporation）等產業巨頭佔了市場主導地位。這些公司憑藉涵蓋廣泛生命科學領域的多元化產品組合保持優勢。成熟的全球網絡、強大的研發能力和全面的服務鞏固了它們的市場領導地位。

儘管市場集中度較高，但專注於特定細分領域的顛覆性創新仍使市場保持活力和發展勢頭。這些專業公司利用尖端技術開發獨特的解決方案，以解決特定的研究問題，從而在更廣泛的生物技術設備市場中開闢出利潤豐厚的細分領域。例如，2025年12月，全球生命科學工具、試劑和診斷產品供應商Biotechne宣布擴大其下一代Rheo™系統（採用Simple Western™技術）的供應範圍並開始首批出貨。

同樣，2025年12月，牛津儀器公司重點發布了Imaris 11，這是其業界領先的3D/4D顯微鏡影像視覺化和分析軟體的最新一代產品。此次軟體升級增強了研究人員處理複雜生物成像數據的能力，透過更先進的可視化和分析工具，能夠提供更深入的洞察。此外，2025年10月，公認的桌上型器官晶片（OOC）解決方案領導者CNBio發布了其PhysioMimix® Core平台，旨在加速藥物發現和開發。

核心成長驅動因子

在定序通量不斷創新的推動下，生物技術設備市場目前正經歷著深刻的變革，重塑著生物研究的速度和範圍。定序技術的進步徹底改變了我們分析遺傳物質的能力，其速度、精度和深度都達到了前所未有的水平，使科學家能夠揭開複雜的生物學謎題，並加速基因組學、個性化醫療和分子診斷等多個領域的發現。這種技術能力的指數級成長不僅提高了研究效率，也拓展了生物技術設備在學術界和商業領域的潛在應用。

新機遇

未來生物技術設備市場的需求正迅速轉向整合多組學平台和自動化工作流程。這些先進平台顯著減少了人為幹預，並將基因組學、蛋白質組學、代謝組學和轉錄組學等多種組學技術整合到系統中，從而對生物樣本進行全面、高通量的分析。透過整合多層生物數據，這些平台能夠深入洞察複雜的生物過程，加速研發進程，並提高藥物開發和診斷的準確性。這些工作流程中對自動化的重視源於提高效率、減少錯誤和增強可重複性的需要——這對於滿足現代生物技術研究日益增長的需求至關重要。

優化障礙

生技設備市場目前面臨著與資本成本和資產估值相關的重大挑戰，這些挑戰對市場成長構成了顯著的阻力。利率上升推高了借貸成本，使得企業更難取得用於購買新設備和擴大基礎設施的融資。這種財務壓力在預算有限且研發活動嚴重依賴外部資金的中小型生技公司中尤為突出。因此，這些公司在支出方面變得更加謹慎，並且越來越多地推遲或縮減對關鍵生物技術設備的投資。

目錄

第一章：摘要整理：全球生技設備市場

第二章：研究方法與架構

  • 研究目標
  • 產品概述
  • 市場區隔
  • 質性研究
    • 一手和二手資料來源
  • 量化研究
    • 一手和二手資料來源
  • 按地區劃分的一手調查受訪者組成
  • 研究假設
  • 市場規模估算
  • 資料三角驗證

第三章：全球生技設備市場概論

  • 產業價值鏈分析
    • 原料供應商
    • 製造商
    • 經銷商
    • 終端用戶
  • 行業展望
    • 全球研發支出
    • 全球生物技術中心（2025 年）
  • PESTLE 分析
  • 波特五力分析
    • 供應商議價能力
    • 買方議價能力
    • 替代品威脅
    • 新進入者威脅
    • 競爭強度
  • 市場成長與展望
    • 市場收入估計與預測（2020-2035 年）
    • 市場估計與預測（基於銷售），2020-2035 年
    • 依產品類型劃分的價格趨勢分析
  • 市場吸引力分析
    • 依產品類型
    • 按地區
  • 可操作的洞見（分析師建議）

第四章：競爭格局概覽

  • 市場集中度
  • 公司佔有率分析（基於價值，2025 年）
  • 競爭格局分析與標竿分析

第五章：全球生技設備市場分析

  • 市場動態與趨勢
    • 成長驅動因素
    • 限制因素
    • 機遇
    • 關鍵趨勢
  • 市場規模及預測（2020-2035 年）
    • 依產品類型
      • 分析儀器
      • 聚合酶鍊式反應 (PCR)
      • 光譜儀
      • 顯微鏡
      • 色譜儀
      • 流式細胞儀
      • 定序儀
      • 微陣列
      • 其他
      • 細胞培養設備
      • 培養系統
      • 培養箱
      • 冷凍保存設備
      • 生物安全設備
      • 移液器
      • 細胞分離設備
      • 離心機
      • 過濾系統
      • 磁激活細胞分離系統
      • 免疫分析設備
      • 臨床化學分析儀
      • 其他
    • 依應用領域分類
      • 製藥和生技公司
      • 醫院和診斷實驗室
      • 學術研究機構
      • 其他
    • 按地區

第六章：北美生技設備市場分析

第七章：歐洲生技設備市場分析

第八章：亞太生物技術設備市場分析

第九章：中東和非洲生物技術設備市場分析

第十章：南美洲生技設備市場分析

第十一章：公司簡介

  • AngioDynamics
  • Alcon
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Bio-Rad Laboratories
  • PerkinElmer
  • Illumina
  • Danaher
  • Merck KGaA
  • GE醫療集團
  • 沃特世公司
  • 賽多利斯股份公司
  • 愛本多股公司
  • 其他主要公司

第十二章：附錄

簡介目錄
Product Code: AA01261631

The Biotechnology Instruments Market is currently experiencing robust growth, reflecting the expanding role of biotechnology in healthcare, research, and industrial applications. Valued at US$ 92.12 billion in 2025, the market is projected to reach a substantial valuation of US$ 141.70 billion by 2035. This anticipated growth corresponds to a compound annual growth rate (CAGR) of 4.4% during the forecast period from 2026 to 2035, indicating steady and sustained expansion over the coming decade. The increasing demand for advanced biotechnology instruments is a key factor driving this positive market trajectory, as these tools are essential for enabling cutting-edge research and development across multiple disciplines.

Several critical factors underpin this market growth. One major driver is the surge in research and development activities focused on personalized medicine, which tailors treatments based on individual genetic profiles. The expanding use of genomics and related technologies requires sophisticated instruments capable of high-throughput and precise analysis, fueling demand across the biotechnology instruments sector. Additionally, the rising prevalence of chronic diseases worldwide has heightened the need for improved diagnostic and therapeutic solutions, prompting increased investment in biotechnology research.

Noteworthy Market Developments

The biotechnology instruments market is characterized by significant consolidation at the top, with industry giants such as Thermo Fisher Scientific and Danaher Corporation commanding the lion's share of the market. These major players maintain their dominance through extensive and diverse product portfolios that span a wide range of life sciences applications. Their established global reach, robust research and development capabilities, and comprehensive service offerings have solidified their positions as market leaders.

Despite this concentration of power among the largest corporations, the market remains vibrant and dynamic due to the presence of specialized challengers who are driving disruptive innovation in targeted niches. These specialized companies are leveraging cutting-edge technologies to develop unique solutions that address specific research challenges, allowing them to carve out lucrative segments within the broader biotechnology instruments landscape. For instance, in December 2025, Bio-Techne Corporation, a global provider of life science tools, reagents, and diagnostic products, announced the expanded launch and first shipment of its next-generation Leo(TM) System, which is powered by Simple Western(TM) Technology.

Similarly, Oxford Instruments made headlines in December 2025 with the release of Imaris 11, the latest generation of its industry-leading 3D/4D microscopy image visualization and analysis software. This software upgrade delivers enhanced capabilities for researchers working with complex biological imaging data, enabling deeper insights through more sophisticated visualization and analysis tools. Additionally, in October 2025, CN Bio, a recognized leader in benchtop Organ-on-a-chip (OOC) solutions designed to accelerate drug discovery and development, launched its PhysioMimix(R) Core platform.

Core Growth Drivers

The biotechnology instruments market is currently undergoing a significant transformation, driven by relentless innovation in sequencing throughput that is reshaping the pace and scope of biological research. Advances in sequencing technology have revolutionized the ability to analyze genetic material with greater speed, accuracy, and depth than ever before, enabling scientists to unravel complex biological questions and accelerate discoveries across diverse disciplines such as genomics, personalized medicine, and molecular diagnostics. This surge in technological capability is not only enhancing research efficiency but also expanding the potential applications of biotechnology instruments in both academic and commercial settings.

Emerging Opportunity Trends

Future demand within the biotechnology instruments market is increasingly shifting toward integrated multi-omics platforms and automated workflows that significantly reduce the need for human intervention. These advanced platforms combine various omics technologies-such as genomics, proteomics, metabolomics, and transcriptomics-into unified systems that enable comprehensive, high-throughput analysis of biological samples. By integrating multiple layers of biological data, these platforms provide deeper insights into complex biological processes, accelerating research and improving the precision of drug development and diagnostics. The emphasis on automation within these workflows is driven by the need to enhance efficiency, reduce errors, and increase reproducibility, all of which are critical for meeting the growing demands of modern biotechnology research.

Barriers to Optimization

The biotechnology instruments market is currently confronting notable challenges related to capital costs and asset valuations, which are creating significant headwinds for growth. Elevated interest rates have increased the cost of borrowing, making it more expensive for companies to finance new equipment purchases or expand their infrastructure. This financial pressure is particularly pronounced for smaller biotechnology firms that typically operate with limited budgets and rely heavily on external funding to support their research and development activities. As a result, these firms are adopting a more cautious approach to spending, often delaying or scaling back investments in essential biotechnology instruments.

Detailed Market Segmentation

By Product, the analytical instruments segment holds a commanding and undisputed position, capturing a substantial revenue share of 65.3%. This dominant share underscores the critical importance of analytical instruments in the life sciences industry, where they serve as the operational heartbeat of research, development, and manufacturing processes. These instruments provide the foundational capabilities necessary for molecular characterization, enabling scientists to analyze the structure, composition, and behavior of biological molecules with precision and accuracy.

By End-use, the pharmaceutical and biotechnology companies segment stands out as the primary force driving the growth of the biotechnology instruments market, accounting for more than 55% of the total revenue generated in this sector. This dominance reflects the critical role these companies play in advancing research and development activities that rely heavily on sophisticated biotechnology instruments. Their substantial investment in cutting-edge tools and technologies is essential to support various stages of drug discovery, testing, and manufacturing, positioning this segment at the forefront of market demand.

Segment Breakdown

By Product

  • Analytical Instruments
  • Polymerase Chain Reaction
  • Spectroscopy
  • Microscopy
  • Chromatography
  • Flow Cytometry
  • Sequencing
  • Microarray
  • Others
  • Cell Culture Instruments
  • Culture Systems
  • Incubators
  • Cryostorage Equipment
  • Biosafety Equipment
  • Pipetting Instruments
  • Cell Separation Instruments
  • Centrifuge
  • Filtration Systems
  • Magnetic-activated Cell Separator Systems
  • Immunoassay Instruments
  • Clinical Chemistry Analyzers
  • Others

By End-use

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Laboratories
  • Academic & Research Institutes
  • Others

By Region

  • North America
  • The US
  • Canada
  • Mexico
  • Europe
  • Western Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Western Europe
  • Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia and New Zealand
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of MEA
  • South America
  • Argentina
  • Brazil
  • Rest of South America

Geography Breakdown

  • North America continues to be the undisputed epicenter of demand in the global biotechnology instruments market, a position largely driven by the region's extensive pharmaceutical infrastructure and significant government funding. This dominance is reflected in the substantial physical presence of major industry players across the continent, particularly in the United States. The country remains the primary engine powering the market, supported by a robust ecosystem where large pharmaceutical companies, often referred to as "Big Pharma," operate with unparalleled financial resources.
  • Beyond the considerable corporate expenditures, the North American biotechnology instruments market also benefits from a revitalized investment climate that encourages rapid adoption of new technologies. Government initiatives, grants, and public-private partnerships contribute to an environment conducive to innovation and growth. This supportive ecosystem enables companies to quickly integrate advanced instruments into their workflows, accelerating scientific discovery and commercial applications.

Leading Market Participants

  • AngioDynamics
  • Alcon
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Bio-Rad Laboratories
  • PerkinElmer
  • Illumina
  • Danaher
  • Merck KGaA
  • GE Healthcare
  • Waters Corporation
  • Sartorius AG
  • Eppendorf AG
  • Other Prominent Players

Table of Content

Chapter 1. Executive Summary: Global Biotechnology Instruments Market

Chapter 2. Research Methodology & Research Framework

  • 2.1. Research Objective
  • 2.2. Product Overview
  • 2.3. Market Segmentation
  • 2.4. Qualitative Research
    • 2.4.1. Primary & Secondary Sources
  • 2.5. Quantitative Research
    • 2.5.1. Primary & Secondary Sources
  • 2.6. Breakdown of Primary Research Respondents, By Region
  • 2.7. Assumption for Study
  • 2.8. Market Size Estimation
  • 2.9. Data Triangulation

Chapter 3. Global Biotechnology Instruments Market Overview

  • 3.1. Industry Value Chain Analysis
    • 3.1.1. Raw Material Suppliers
    • 3.1.2. Manufacturers
    • 3.1.3. Distributors
    • 3.1.4. End Consumers
  • 3.2. Industry Outlook
    • 3.2.1. Global R&D Expenditure
    • 3.2.2. Top Biotechnology Hubs in the World, 2025
  • 3.3. PESTLE Analysis
  • 3.4. Porter's Five Forces Analysis
    • 3.4.1. Bargaining Power of Suppliers
    • 3.4.2. Bargaining Power of Buyers
    • 3.4.3. Threat of Substitutes
    • 3.4.4. Threat of New Entrants
    • 3.4.5. Degree of Competition
  • 3.5. Market Growth and Outlook
    • 3.5.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2035
    • 3.5.2. Market Volume Estimates and Forecast (Units), 2020-2035
    • 3.5.3. Price Trend Analysis, By Product Type
  • 3.6. Market Attractiveness Analysis
    • 3.6.1. By Product Type
    • 3.6.2. By Region
  • 3.7. Actionable Insights (Analyst's Recommendations)

Chapter 4. Competition Dashboard

  • 4.1. Market Concentration Rate
  • 4.2. Company Market Share Analysis (Value %), 2025
  • 4.3. Competitor Mapping & Benchmarking

Chapter 5. Global Biotechnology Instruments Market Analysis

  • 5.1. Market Dynamics and Trends
    • 5.1.1. Growth Drivers
    • 5.1.2. Restraints
    • 5.1.3. Opportunity
    • 5.1.4. Key Trends
  • 5.2. Market Size and Forecast, 2020-2035 (US$ Mn & Units)
    • 5.2.1. By Product Type
      • 5.2.1.1. Key Insights
        • 5.2.1.1.1. Analytical Instruments
          • 5.2.1.1.1.1. Polymerase Chain Reaction
          • 5.2.1.1.1.2. Spectroscopy
          • 5.2.1.1.1.3. Microscopy
          • 5.2.1.1.1.4. Chromatography
          • 5.2.1.1.1.5. Flow Cytometry
          • 5.2.1.1.1.6. Sequencing
          • 5.2.1.1.1.7. Microarray
          • 5.2.1.1.1.8. Others
        • 5.2.1.1.2. Cell Culture Instruments
          • 5.2.1.1.2.1. Culture Systems
          • 5.2.1.1.2.2. Incubators
          • 5.2.1.1.2.3. Cryostorage Equipment
          • 5.2.1.1.2.4. Biosafety Equipment
          • 5.2.1.1.2.5. Pipetting Instruments
        • 5.2.1.1.3. Cell Separation Instruments
          • 5.2.1.1.3.1. Centrifuge
          • 5.2.1.1.3.2. Filtration Systems
          • 5.2.1.1.3.3. Magnetic-activated Cell Separator Systems
        • 5.2.1.1.4. Immunoassay Instruments
        • 5.2.1.1.5. Clinical Chemistry Analyzers
        • 5.2.1.1.6. Others
    • 5.2.2. By End-Use
      • 5.2.2.1. Key Insights
        • 5.2.2.1.1. Pharmaceutical & Biotechnology Companies
        • 5.2.2.1.2. Hospitals & Diagnostic Laboratories
        • 5.2.2.1.3. Academic & Research Institutes
        • 5.2.2.1.4. Others
    • 5.2.3. By Region
      • 5.2.3.1. Key Insights
        • 5.2.3.1.1. North America
          • 5.2.3.1.1.1. The U.S.
          • 5.2.3.1.1.2. Canada
          • 5.2.3.1.1.3. Mexico
        • 5.2.3.1.2. Europe
          • 5.2.3.1.2.1. Western Europe
            • 5.2.3.1.2.1.1. The UK
            • 5.2.3.1.2.1.2. Germany
            • 5.2.3.1.2.1.3. France
            • 5.2.3.1.2.1.4. Italy
            • 5.2.3.1.2.1.5. Spain
            • 5.2.3.1.2.1.6. Rest of Western Europe
          • 5.2.3.1.2.2. Eastern Europe
            • 5.2.3.1.2.2.1. Poland
            • 5.2.3.1.2.2.2. Russia
            • 5.2.3.1.2.2.3. Rest of Eastern Europe
        • 5.2.3.1.3. Asia Pacific
          • 5.2.3.1.3.1. China
          • 5.2.3.1.3.2. India
          • 5.2.3.1.3.3. Japan
          • 5.2.3.1.3.4. South Korea
          • 5.2.3.1.3.5. Australia & New Zealand
          • 5.2.3.1.3.6. ASEAN
              • 5.2.3.1.3.6.1.1. Indonesia
              • 5.2.3.1.3.6.1.2. Malaysia
              • 5.2.3.1.3.6.1.3. Thailand
              • 5.2.3.1.3.6.1.4. Singapore
              • 5.2.3.1.3.6.1.5. Rest of ASEAN
          • 5.2.3.1.3.7. Rest of Asia Pacific
        • 5.2.3.1.4. Middle East & Africa
          • 5.2.3.1.4.1. UAE
          • 5.2.3.1.4.2. Saudi Arabia
          • 5.2.3.1.4.3. South Africa
          • 5.2.3.1.4.4. Rest of MEA
        • 5.2.3.1.5. South America
          • 5.2.3.1.5.1. Argentina
          • 5.2.3.1.5.2. Brazil
          • 5.2.3.1.5.3. Rest of South America

Chapter 6. North America Biotechnology Instruments Market Analysis

  • 6.1. Market Dynamics and Trends
    • 6.1.1. Growth Drivers
    • 6.1.2. Restraints
    • 6.1.3. Opportunity
    • 6.1.4. Key Trends
  • 6.2. Market Size and Forecast, 2020-2035 (US$ Mn & Units)
    • 6.2.1. By Product Type
    • 6.2.2. By End-Use
    • 6.2.3. By Country

Chapter 7. Europe Biotechnology Instruments Market Analysis

  • 7.1. Market Dynamics and Trends
    • 7.1.1. Growth Drivers
    • 7.1.2. Restraints
    • 7.1.3. Opportunity
    • 7.1.4. Key Trends
  • 7.2. Market Size and Forecast, 2020-2035 (US$ Mn & Units)
    • 7.2.1. By Product Type
    • 7.2.2. By End-Use
    • 7.2.3. By Country

Chapter 8. Asia Pacific Biotechnology Instruments Market Analysis

  • 8.1. Market Dynamics and Trends
    • 8.1.1. Growth Drivers
    • 8.1.2. Restraints
    • 8.1.3. Opportunity
    • 8.1.4. Key Trends
  • 8.2. Market Size and Forecast, 2020-2035 (US$ Mn & Units)
    • 8.2.1. By Product Type
    • 8.2.2. By End-Use
    • 8.2.3. By Country

Chapter 9. Middle East & Africa Biotechnology Instruments Market Analysis

  • 9.1. Market Dynamics and Trends
    • 9.1.1. Growth Drivers
    • 9.1.2. Restraints
    • 9.1.3. Opportunity
    • 9.1.4. Key Trends
  • 9.2. Market Size and Forecast, 2020-2035 (US$ Mn & Units)
    • 9.2.1. By Product Type
    • 9.2.2. By End-Use
    • 9.2.3. By Country

Chapter 10. South America Biotechnology Instruments Market Analysis

  • 10.1. Market Dynamics and Trends
    • 10.1.1. Growth Drivers
    • 10.1.2. Restraints
    • 10.1.3. Opportunity
    • 10.1.4. Key Trends
  • 10.2. Market Size and Forecast, 2020-2035 (US$ Mn & Units)
    • 10.2.1. By Product Type
    • 10.2.2. By End-Use
    • 10.2.3. By Country

Chapter 11. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

  • 11.1. AngioDynamics
  • 11.2. Alcon
  • 11.3. Thermo Fisher Scientific
  • 11.4. Agilent Technologies
  • 11.5. Bio-Rad Laboratories
  • 11.6. PerkinElmer
  • 11.7. Illumina
  • 11.8. Danaher
  • 11.9. Merck KGaA
  • 11.10. GE Healthcare
  • 11.11. Waters Corporation
  • 11.12. Sartorius AG
  • 11.13. Eppendorf AG
  • 11.14. Other Prominent Players

Chapter 12. Annexure

  • 12.1. List of Secondary Leather Types
  • 12.2. Key Country Markets- Macro Economic Outlook/Indicators